Driving With Cardiovascular Disease: The Impact of Implantable Cardioverter Defibrillators on Driver Safety by Williams, Jessica R & Tregear, Aaron J
Masthead Logo
University of Iowa
Iowa Research Online
Driving Assessment Conference 2009 Driving Assessment Conference
Jun 23rd, 12:00 AM
Driving With Cardiovascular Disease: The Impact
of Implantable Cardioverter Defibrillators on
Driver Safety
Jessica R. Williams
MANILA Consulting Group, Inc., McLean, VA
Stephen J. Tregear
MANILA Consulting Group, Inc., McLean, VA
Follow this and additional works at: https://ir.uiowa.edu/drivingassessment
This Event is brought to you for free and open access by the Public Policy Center at Iowa Research Online. It has been accepted for inclusion in Driving
Assessment Conference by an authorized administrator of Iowa Research Online. For more information, please contact lib-ir@uiowa.edu.
Williams, Jessica R. and Tregear, Stephen J.. Driving With Cardiovascular Disease: The Impact of Implantable Cardioverter
Defibrillators on Driver Safety. In: Proceedings of the Fifth International Driving Symposium on Human Factors in Driver
Assessment, Training and Vehicle Design, June 22-25, 2009, Big Sky, Montana. Iowa City, IA: Public Policy Center, University of Iowa,
2009: 147-153. https://doi.org/10.17077/drivingassessment.1315
PROCEEDINGS of the Fifth International Driving Symposium on Human Factors in Driver Assessment, Training and Vehicle Design 
147 
DRIVING WITH CARDIOVASCULAR DISEASE: THE IMPACT OF IMPLANTABLE 
CARDIOVERTER DEFIBRILLATORS ON DRIVER SAFETY 
 
Jessica R. Williams & Stephen J. Tregear 
MANILA Consulting Group, Inc. 
McLean, Virginia, USA 
Email: jwilliams@manilaconsulting.net 
 
Summary: Cardiovascular disease (CVD) is the leading cause of death in the 
United States. With America’s workforce rapidly aging, more attention is being 
placed on CVD and its treatment among employees in safety sensitive 
occupations, such as the transportation industry. Implantable cardioverter 
defibrillators (ICDs) are increasingly being used to treat certain cardiovascular 
conditions, but despite the fact that they are effective in preventing sudden death 
from cardiac arrhythmia, there is concern about allowing individuals with an ICD 
to drive. A systematic review and meta-analysis was conducted to examine the 
health and safety impacts ICDs on driving. We considered data pertaining to four 
outcomes among individuals with an ICD: crash rate, the occurrence of sudden 
death while driving, the occurrence of syncope while driving, and the occurrence 
of at least one shock from their ICD while driving. Currently, the impact of an 
ICD on driver safety cannot be determined. Our assessments of the evidence 
pertaining to crash rates and sudden incapacitation while driving were 
inconclusive. Our results do indicate, however, that some individuals with an ICD 
will experience an inappropriate ICD discharge while driving (Strength of 
Evidence Rating: Strong). Experiencing such a discharge while driving is a 
potential hazard to driver safety. Quantitative assessment of the available data 
suggests that approximately 6.3% (95% CI: 4.7%-8.4%) of all individuals with an 
ICD who drive will experience a discharge while driving. These findings have 
potential implications for regulatory agencies with responsibility for road safety; 
particularly those agencies that regulate safety sensitive industries.  
 
INTRODUCTION 
 
Driving is a complicated psychomotor performance that depends on fine coordination between 
the sensory and motor systems. It is influenced by factors such as arousal, perception, learning, 
memory, attention, concentration, emotion, reflex speed, time estimation, auditory and visual 
functions, decision making and personality. Safe driving requires skills to maintain effective and 
reliable control of vehicles, the capacity to respond to the road, traffic, and other external clues, 
and the ability to follow the “rules of the road”. Many health conditions exist which have the 
potential to impair perception, cognition (including alertness, attitude to risk, and recall) and/or 
motor function and, as a result, can make driving less safe.  
 
Cardiovascular disease (CVD) is the leading cause of death in the United States, accounting for 
approximately 1 out of every 2.8 deaths (American Heart Association, 2008). In America’s aging 
workforce, more attention is being placed on the implications of CVD and its treatment among 
employees in safety sensitive occupations, such as the transportation industry. Cardiac 
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arrhythmia is a type of CVD described as any change in heartbeat rhythm from the normal 
sequence of electrical impulses in the heart (AHA, 2006). Implantable Cardioverter 
Defibrillators (ICDs) are increasingly being used to treat life-threatening arrhythmias. An ICD is 
a battery-powered, fully implantable device consisting of the device and one or more leads. 
These leads monitor heart rhythm and have the capacity to deliver an electrical shock to restore 
normal sinus rhythm when potentially life-threatening ventricular arrhythmias are detected.  
 
Despite the fact that ICDs have been shown to be effective in preventing sudden death resulting 
from cardiac arrhythmia, there is legitimate concern about the consequences of allowing 
individuals with an ICD to drive (Epstein et al., 2008). These concerns include the following: 1) 
ICDs, while effective, do not completely eliminate the risk for sudden cardiac death (SCD); 2) 
even the rapid intervention of an ICD following the onset of an arrhythmia may not be enough to 
protect against driving impairment since sudden incapacitation resulting from syncope may still 
occur; 3) ICD discharges, whether appropriate or not, may startle or temporarily incapacitate the 
patient and thereby disrupt safe motor vehicle operation.  
 
The purpose of this study was to answer a critical question about the health and safety impacts of 
ICDs on driving; namely, should individuals with an ICD be allowed to drive? The specific 
objectives were to: 1) assess the risk of motor vehicle crash among individuals following the 
implantation of an ICD; 2) determine the proportion of individuals with an ICD who experience 
syncope and sudden death while driving; and 3) examine the number of individuals who received 
at least one shock from their ICD while driving. 
 
METHODS 
 
In order to address our objectives, a systematic review of the literature was conducted (Treadwell 
et al., 2006). We synthesized the available data from published studies that examined the 
incidence of sudden death and sudden incapacitation due to syncope among drivers with an ICD, 
and studies that examined the occurrence of ICD discharge during driving. Formal a priori 
criteria for article retrieval and inclusion consisted of: 1) English language publications, 2) full-
length articles, 3) enrolled ≥ 10 subjects, 4) subjects must be ≥ 18 years, 5) article must describe 
a study that assessed the occurrence of crash, SCD, sudden incapacitation due to syncope, or ICD 
discharge during driving. Case reports and series of carefully selected patients chosen to 
demonstrate a particular point were excluded. 
 
Sensitive search strategies, developed and refined by an information specialist, were applied to 
seven electronic databases (Medline, PubMed (pre Medline), EMBASE, PSYCHInfo, CINAHL, 
TRIS, and the Cochrane library). Additional hand searches of the published literature (i.e., 
bibliographies of identified relevant articles) and “gray literature” resources (e.g., Web searches) 
were also performed. The quality of all included studies was determined using the ECRI Quality 
Scale VI, which was designed specifically for the assessment of the validity of surveys. Fixed-
effects meta-analysis was used to pool data from different studies. Sensitivity analyses, aimed at 
testing the robustness of our findings, included the use of cumulative fixed-effects meta-analysis.  
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RESULTS 
 
Identification of Evidence Base 
 
Our searches identified a total of 427 articles that appeared relevant to the purpose of this study. 
Following application of the retrieval criteria, 69 full-length articles retrieved and read in full. Of 
these articles, 7 were found to meet our inclusion criteria.  
 
Description of Evidence Base 
 
All seven studies that met our inclusion criteria employed a survey design. Only two studies 
included a comparison group (Akiyama et al., 2001; Conti et al., 1997) and only one study 
considered driving exposure (Conti et al., 1997). The quality assessment scores for each of these 
seven articles were “Low”, with the exception of Curtis et al. (1995), which was deemed to be of 
“Extremely Low” quality. “Extremely Low” quality studies are considered to be fatally flawed, 
and therefore, we did not consider outcome data from this study any further in this report. The 
primary reasons for the “Low” quality rating of the other studies include the reliance on surveys 
to collect data and the high non-response rates found in some of the studies. With regards to 
generalizability, subjects in this small group of studies were generally male, but older than would 
be expected for the average CMV driver. Driving distances were not addressed in these studies; 
however, a number of other papers indicated that most ICD recipients discontinued driving, 
drove fewer miles, or modified their driving habits in some way by not driving in inclement 
weather, avoiding peak traffic and engaging in similar precautions. 
 
Motor Vehicle Crash among Individuals with ICD 
 
Four of the six included studies presented data on the number or frequency of crashes that 
occurred among individuals with an ICD. These data are summarized in Table 1. 
 
Table 1. Crash Data Extracted from Included ICD Studies 
Reference Year Number 
of 
Drivers 
Mean FUT ±SD 
(months) 
Number Who 
Crashed at Least 
Once (%) 
Number of Crashes 
at Fault (%) 
Number of Total 
Crashes Related to 
CVD (%) 
Trappe et al. 1998 171 38 ±24 11 (6.4) 1 (9.1) 0 (0.0) 
Conti et al. 1997 73 5.3 years ±NR 0 (0.0) 0 (0.0) 0 (0.0) 
Finch et al. 1997 81 21.6 ±NR 0 (0.0) 0 (0.0) 0 (0.0) 
Finch et al. 1993 28 NR ±NR Range: 1 to 36 0 (0.0) 0 (0.0) 0 (0.0) 
* Investigators did not present crash data for two groups separately. Rather they reported on the overall number of crashes 
experienced by individuals treated with an ICD and pharmacotherapy and merely noted that crash rate was lower in ICD 
group. 
CVD Cardiovascular disease. 
ICD Implantable cardioverter defibrillator. 
NR Not reported. 
SD Standard deviation. 
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Crashes reportedly occurred in only one of the four included studies. Trappe et al. (1998) noted 
that 11 individuals enrolled in their study experienced at least one crash during follow-up. Of 
these, only one was determined to be the fault of the driver, and none of the crashes were the 
consequence of either CVD or an event associated with the implanted ICD. No crashes were 
reported to have occurred among the individuals enrolled in the remaining three studies. This 
may be the combined consequence of the small size of these studies and their short follow-up 
times. In order to determine a reliable estimate of the crash rate associated with ICDs, studies 
with far larger sample sizes and longer follow-up times will need to be performed. 
 
Occurrence of Syncope and Sudden Death while Driving 
 
Three of the six included studies reported on the occurrence of syncope and sudden death while 
an individual with an ICD was driving. Relevant data from these studies are summarized in 
Table 2. 
Table 2. Number of Individuals who Experienced Syncope or SCD while Driving 
Reference Year N = 
Number 
of 
Drivers 
Mean FUT 
±SD 
Number who 
Experienced 
Syncope (%) 
Number 
Who 
Experienced 
Syncope 
While 
Driving (%) 
Number 
Who 
Experienced 
Sudden-
Cardiac 
Death (%) 
Number 
Who 
Experienced 
Sudden-
Cardiac 
Death While 
Driving (%) 
Trappe et al. 1998 241 171 
38 ±28 
Range: <1 
to124 
15 (5.2) 0 (0.0) 8 (2.8) 0 (0.0) 
Finch et al. 1997 105 81 21.6 ±NR 1 (1.2) 0 (0.0) 0 (0.0) 0 (0.0) 
Finch et al. 1993 40 28 Range: 1 to 36 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 
FUT Follow-up time. 
NR Not reported. 
SCD Sudden cardiac death. 
SD Standard deviation. 
 
None of the individuals enrolled in the three included studies above experienced syncope or SCD 
while driving. 
 
Occurrence of ICD Discharge while Driving 
 
All six included studies reported on the occurrence of ICD discharge during driving. Relevant 
data from these studies are summarized in Table 3. 
 
In order to obtain an estimate of the expected proportion of individuals with an ICD who might 
be expected to experience at least one ICD discharge shock during follow-up, we pooled data 
from all six studies using meta-analysis. Despite the fact that follow-up times varied across 
studies, homogeneity testing found that the ICD discharge data were consistent (Q = 6.516, P = 
0.259; I2 = 23.268). Because these data were homogeneous, we pooled them using a fixed-effects 
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Table 3. Number of Individuals with ICD who Experience Shock while Driving 
Reference Year N = 
Number 
of 
Drivers 
Mean FUT ±SD 
Number Who 
Experienced Shock 
During Follow-up (%) 
Number Who 
Experienced Shock 
While Driving (%) 
Akiyama et 
al. 2001 328 295 
35 ±NR 
Range: NR NR 24 (8.1) 
Trappe et 
al. 1998 241 171 
38 ±28 
Range:<1 to124 224 (77.0) 8 (4.7) 
Conti et al. 1997 85 73 5.3 years ±NR Range: NR 52 (63.4) 0 (0.0)* 
Finch et al. 1997 105 81 21.6 ±NR Range: NR 52 (49.5) 3 (3.7) 
Craney and 
Powers 1995 97 72 
26 ±NR 
Range: 6 to 108 42 (43.3) 3 (4.1) 
Finch et al. 1993 40 28 Range: 1 to 36 26 (65.0) 2 (7.1) 
 * Discharges during previous 12 months only. 
FUT Follow-up time. 
ICD Implantable cardioverter defibrillator. 
SD Standard deviation. 
model. The results of this analysis are presented in Figure 1. According to the findings of this 
analysis, the number of individuals with an ICD who will experience at least one shock during 
driving (appropriate or inappropriate) is in the order of 6.3% (95% CI: 4.7–8.4%). A series of 
sensitivity analyses found the findings of this analysis to be robust. 
 
Figure 1. Proportion of Individuals who Experienced ICD Discharge during Driving 
 
Time to First ICD Discharge while Driving 
 
None of the included studies reported on the time to first ICD discharge during driving. 
However, Trappe et al. (1998) reported on the time interval from ICD implantation to first 
discharge among drivers and non-drivers. No significant differences among drivers and non-
drivers in the interval postimplant to first discharge were observed. The mean time to first ICD 
Study name Statistics for each study Event rate and 95% CI
Event Lower Upper 
rate limit limit Z-Value p-Value
Akayama 0.081 0.055 0.119 -11.382 0.000
Trappe 0.047 0.024 0.091 -8.324 0.000
Conti 0.007 0.000 0.099 -3.517 0.000
Finch (1997) 0.037 0.012 0.109 -5.538 0.000
Craney and Powers 0.042 0.014 0.121 -5.316 0.000
Finch 0.071 0.018 0.245 -3.495 0.000
0.063 0.047 0.084 -16.608 0.000
-0.25 -0.13 0.00 0.13 0.25
PROCEEDINGS of the Fifth International Driving Symposium on Human Factors in Driver Assessment, Training and Vehicle Design 
152 
discharge was 9 months (SD: 12) and among non-drivers 9 months (SD: 10). First ICD discharge 
was delivered within the first 6 months postimplant in 52% of drivers and 53% of non-drivers. 
 
Risk Factors for ICD Discharge while Driving 
 
In an attempt to identify individuals who are at most risk for an ICD discharge during driving, 
Trappe et al. (1998) performed a multivariate analysis. This analysis included data about age, 
gender, underlying disease, LVEF, spontaneous arrhythmias before ICD implant, induced 
arrhythmias during the electrophysiology study, defibrillation threshold, antiarrhythmic drugs, 
other drugs (i.e., digitalis, diuretics, ACE inhibitors, nitrates), and types of implanted devices 
(i.e., monophasic or biphasic waveform shocks, ICD with or without antitachycardia pacing 
modalities). These investigators were unable to identify any characteristics that could be used to 
identify individuals who are at most risk for an ICD discharge during driving. None of the 
remaining included studies attempted to identify which individuals with an ICD presented the 
most risk for ICD discharge during driving. 
 
DISCUSSION 
 
Our assessments of the evidence pertaining to crash rates and sudden incapacitation while 
driving were inconclusive. None of the included studies compared crash rates occurring among 
individuals with an ICD to crash rates among individuals without CVD. Consequently, it is not 
possible to determine whether individuals with an ICD are at increased risk for a motor vehicle 
crash. In the three studies that examined the occurrence of syncope and sudden death while an 
individual with an ICD was driving, no study participants experienced syncope or SCD while 
driving. Given the fact that syncope and sudden-death while driving have to be considered as 
rare events, the fact that no cases were observed in the three included studies cannot be 
considered as evidence that such events will not occur while driving. 
 
The results of our analyses do indicate, however, that some individuals with an ICD will 
experience an ICD discharge while driving (Strength of Evidence Rating: Strong). Experiencing 
such a discharge while driving is a potential hazard to driver safety. Quantitative assessment of 
the available data suggests that approximately 6.3% (95% CI: 4.7%-8.4%) of all individuals with 
an ICD who drive will experience a discharge while driving. A series of sensitivity analyses 
found the findings of this analysis to be robust. Despite the fact that follow-up times varied 
across studies, no relationship was found between follow-up time and number of discharges. 
This is probably due to the low event rate which, consequently, increases variance and impairs 
the ability to detect heterogeneity. These findings have potential implications for regulatory 
agencies with responsibility for road safety; particularly those agencies that regulate safety 
sensitive industries.  
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